tiprankstipranks
Turnstone Biologics Corp. (TSBX)
NASDAQ:TSBX
US Market

Turnstone Biologics Corp. (TSBX) Income Statement

Compare
47 Followers

Turnstone Biologics Corp. Income Statement

Last quarter (Q3 2024), Turnstone Biologics Corp.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Turnstone Biologics Corp.'s net income was $-17.03M. See Turnstone Biologics Corp.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21
Total Revenue
$ 19.31M$ 73.30M$ 101.29M
Gross Profit
$ 16.51M$ 71.10M$ 99.28M
Operating Expenses
$ 78.34M$ 104.93M$ 68.30M
Depreciation and Amortization
$ 2.80M$ 2.20M$ 2.01M
EBITDA
$ -56.23M$ -28.49M$ 35.71M
Operating Income
$ -59.03M$ -31.63M$ 32.99M
Other Income/Expenses
$ 3.55M$ 933.00K$ 708.00K
Pretax Income
$ -55.49M$ -30.69M$ 33.70M
Net Income
$ -55.20M$ -30.83M$ 33.27M
Per Share Metrics
$ ―$ ―$ ―
Basic EPS
$ -4.77$ -1.39$ 1.50
Diluted EPS
$ -4.77$ -1.39$ 1.50
Weighted Average Shares Outstanding
11.56M 22.19M 22.19M
Weighted Average Shares Outstanding (Diluted)
11.56M 22.19M 22.19M
Currency in USD

Turnstone Biologics Corp. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis